1 documents found
Information × Registration Number 0106U005224, R & D request Title Randomized, parallel-group, placebo-controlled, phase III study of the efficacy and safety of Quetiapine Fumarate (Seroquel), single oral 300 mg or 600 mg dose) and Lithium as monotherapy in adult an international, multicentre, double-blind,patients with bipolar depression for 8 weeks and Quetiapine in continuation treatment for 26 up to 52 weeks Head Напрєєнко Олександр Констянтинович, Registration Date 10-05-2006 Organization Bogomolets National Medical University, Ministry of Health of Ukraine popup.description1 popup.nrat_date 2024-12-11 Close
search.res_rk
Randomized, parallel-group, placebo-controlled, phase III study of the efficacy and safety of Quetiapine Fumarate (Seroquel), single oral 300 mg or 600 mg dose) and Lithium as monotherapy in adult an international, multicentre, double-blind,patients with bipolar depression for 8 weeks and Quetiapine in continuation treatment for 26 up to 52 weeks
Head: Напрєєнко Олександр Констянтинович. Randomized, parallel-group, placebo-controlled, phase III study of the efficacy and safety of Quetiapine Fumarate (Seroquel), single oral 300 mg or 600 mg dose) and Lithium as monotherapy in adult an international, multicentre, double-blind,patients with bipolar depression for 8 weeks and Quetiapine in continuation treatment for 26 up to 52 weeks. Bogomolets National Medical University, Ministry of Health of Ukraine. № 0106U005224
1 documents found

Updated: 2026-03-25


Роздрукувати цю сторінку